Doctor profile · Federal record
Dr. Mhd Iyad Alshwaf, MD
Rheumatology Physician (CMS: Rheumatology) · Lansing, MI
- NPI 1801399365
- Accepts Medicare
- MIPS 72.5 / 100 · 2023
- 35 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
4052 Legacy Pkwy, Suite 200
Lansing, MI 489114285
(517) 272-9700
Credentials & registration
- NPI registered
- March 2018 — 8 yrs on file
- Profile last updated
- May 4, 2021
- Year of graduation
- 1991 — 35 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- Michigan #4301075752
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1801399365. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
86,982
Distinct HCPCS
10
Medicare allowed
$1,479,771
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3262 |
Injection, tocilizumab, 1 mg | 26,240 | 12 | $6 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 23,100 | 41 | $13 | |
J3111 |
Injection, romosozumab-aqqg, 1 mg | 15,120 | 19 | $10 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 8,250 | 20 | $40 | |
J0897 |
Injection, denosumab, 1 mg | 6,900 | 78 | $23 | |
J0490 |
Injection, belimumab, 10 mg | 3,432 | 13 | $48 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 846 | 460 | $120 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 563 | 276 | $84 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 456 | 87 | $1 | |
96372 |
Injection of drug or substance under skin or into muscle | 431 | 178 | $14 |
In context: peer comparison
Among 1 peers in Lansing Rheumatology Physician, average services per provider: 3,221. This provider delivers 27× the peer median.Open Payments
Industry payments received
All-time total
$3,823
Transactions
201
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Amgen INC. | 28 | $730.63 | |
| Janssen Biotech, INC. | 67 | $712.23 | |
| Abbvie INC. | 42 | $615.91 | |
| AstraZeneca Pharmaceuticals Lp | 13 | $243.85 | |
| Ucb, INC. | 9 | $233.62 | |
| Ani Pharmaceuticals, INC. | 10 | $214.45 | |
| Novartis Pharmaceuticals Corporation | 9 | $200.03 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 2 | $135.25 | |
| United Therapeutics Corporation | 1 | $114.66 | |
| Mallinckrodt Hospital Products INC. | 6 | $112.35 | |
| Organon LLC | 6 | $110.12 | |
| Lilly USA, LLC | 2 | $44.89 | |
| Alexion Pharmaceuticals, INC. | 2 | $43.08 | |
| Sobi, INC | 2 | $42.91 | |
| Pfizer INC. | 2 | $41.17 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,615
Patients
490
Total drug cost
$985,786
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate | Generic | 410 | 135 | $40,329 |
| Methotrexate (Methotrexate Sodium) | Brand | 331 | 99 | $18,174 |
| Prednisone | Generic | 253 | 85 | $4,287 |
| Leflunomide | Generic | 126 | 49 | $10,033 |
| Humira(Cf) Pen (Adalimumab) | Brand | 56 | 0 | $391,981 |
| Meloxicam | Generic | 55 | 28 | $398 |
| Methylprednisolone | Generic | 52 | 28 | $1,255 |
| Mycophenolate Mofetil | Generic | 52 | 12 | $5,291 |
| Enbrel Sureclick (Etanercept) | Brand | 50 | 0 | $360,030 |
| Gabapentin | Generic | 47 | 16 | $886 |
Hospital affiliations
Frequently asked questions
What is Dr. Mhd Iyad Alshwaf's medical specialty?
Dr. Mhd Iyad Alshwaf practices Rheumatology Physician in Lansing, MI.
Where does Dr. Mhd Iyad Alshwaf practice?
Dr. Mhd Iyad Alshwaf practices at 4052 Legacy Pkwy, Lansing, MI 489114285. Office phone: 5172729700.
What is Dr. Mhd Iyad Alshwaf's NPI?
Dr. Mhd Iyad Alshwaf's National Provider Identifier (NPI) is 1801399365, issued by NPPES.
Does Dr. Mhd Iyad Alshwaf accept Medicare assignment?
Yes. Dr. Mhd Iyad Alshwaf accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mhd Iyad Alshwaf commonly perform?
Top Medicare-reported procedures in 2023: Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, romosozumab-aqqg, 1 mg (HCPCS J3111). Source: CMS Medicare Physician & Other Practitioners file.